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We have systematically examined HLA-D region antigen 
expression by normal human epidermal Langerhans cells 
with a n improved double label indirect immunofluores-
cence t echnique in order to better understand the immu-
nologic potential of this human interstitial dendritic cell 
typ e . The results of this study which differ somewhat from 
earlie r observations strongly suggest that 100% of OKT-
6-positive epidermal Langerhans cells constitutively ex-
press HLA-DQ and HLA-DP as well as HLA-DR mole-
I t h as been kno wn for some time no w that human epidermal L a ngerhans cells (ELC) express HLA-DR (class II) antigens . It w as this observation that stimulated a series of studies I vvhich resulted in the demo nstration that this epidermal cell type was capable o f presentin g bo th allo and nominal anti-
gen s. However, over the pas t several yea rs we have come to lea rn 
th a t the human HLA-D region is quite complex Pl. The HLA-
D region, which is present on the short arm of the human sixth 
chroITlosome, is no w kno wn to consist of 3 genetically distinct 
subregions: HLA-DR, HLA-DQ, and HLA-DP. The best-stud-
ied o f these, the HLA-DR subreg ion , codes fo r cell surface gly-
coprote in antigens that are stru cturall y homologous to the murine 
I-E a ntigens and are known to carry the main determinants that 
trigger the primary mixed lymphocyte reaction. DR antigens are 
composed of 2 noncovalently associated subunits, a heavy in-
va ria nt a-chain and a lighter, polymo rphi c ,8-chain . The complex 
polYITlorphism in the amino acid sequences of the multiple DR 
,8-ch a in gene products accounts fo r the allelic variation of the DR 
antigen system that had been previously known to exist from 
gen e tic analyses. Numerous studies have sho wn that human ELC 
constitutively express HLA-DR molecules , but little is known 
abo ut the expression of the other H LA-D region molecules by 
this c e ll type. In addition , several w orkers have suggested that 
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Abbre viations: 
ELC: epidermal Langerhans cell(s) 
FITC: flu orescein isothiocyanate 
IIF : indirect immunofluorescence 
P BS: phosphate-buffered saline 
T RITC: tetramethylrhodamine isothiocyanate 
cules. Since HLA-DQ expression has been positively cor-
related with the ability to present nominal antigen, our 
findin gs would suggest the possibility that epidermal Lan-
gerhans cells, like other members of the human dendritic 
cell series, might be more effi cient than monocytes at no m-
inal antigen presentation since only about 50% of periph-
era l blood monocytes express H LA-DQ molecules . J In vest 
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only a subpopulation o f O KT -6-positive ELC express HLA-D R 
antigens [2-5] . 
The HLA-DQ subregion (previously known as HLA-DC or 
-DS) also codes fo r cell surface anti gens composed of single a-
and ,8-chains that are ho mologous to the murine I-A antigens [6]. 
Recent work has suggested that HLA-DQ molecules might play 
an impo rtant role in the presentation of no minal antigens to au-
to logous T cells. Studies have shown th at human monocytes that 
express both detectable HLA-DR and HLA-DQ antigens are mo re 
effi cient at presenting no minal antigens than are those monocytes 
that express only HLA-DR [7,8]. While other investigato rs have 
idelltified HLA-DQ antigen in adult human epidermis [91, until 
no w there has been no systematic stud y of the ability o f the O KT -
6-positive human ELC to express HLA-DQ gene products. Since 
ELC are known to be efficient nominal an tigen-presenting cells, 
one might predict that these cells would express H LA-DQ gene 
products. If this were the case, it would be of value to know 
whether these antigens were ex pressed by all ELC o r only a 
subpopulation , as has been shown to be the case for human mono-
cytes [7,8]. 
The HLA-D P subregion (previously known as the SB locus) 
also codes for cell surface antigens composed of single a- and ,8-
chains that are the stimulatory antigens in the secondary mixed 
lymphocyte reaction [10] . There have been no previous repo rts 
concerning HLA-DP antigen expression by human ELC . 
We became interested in applying this new knowledge of the 
complexity of the HLA-D region to arrive at a better understand-
ing of class II antigen expression by the human ELC . In a series 
of studies designed to address this issue, we have obtained data 
w hich strongly suggest that all ELC constitutively express gene 
products of all 3 subregions of the HLA-O locus, a finding w hich 
differs from several earlier studies w hich suggested that only a 
subpopulation of OKT-6-positive resting human ELC express 
HLA-DR antigens [2-5]. 
MATERIALS AND M ETHO DS 
Experimental Subjects Four healthy adult volunteers were 
recruited for the study based upon their w illingness to donate 
cutaneous tissue and venous blood f? r HLA typing. All donors 
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were typed for all known HLA-A, -B, -C, -DR, and -DQ an-
tigens using standard serologic techniques with Ninth Interna-
tional Workshop reagents [11]. 
Epidermal Biopsy Technique Seven millimeter-diameter, full-
thickness epidermal biopsies were obtained from fl exor forea rm 
skin of each of the volunteers by a previously described suction 
blister technique [1 2]. 
HLA-D Region Monoclonal Antibodies Murine mono-
clonal antibodies to HLA-D region-encoded molecules included: 
L243, which recognizes a monomorphic determinant of HLA-
DR molecules [13] , a gift of Ronald Levy , Stanford University; 
I-LR2, which recognizes HLA-DR determinants associated with 
the specificity DR w52 [14] , a gift of Lee N adler, Harvard Uni-
versity; 109d6, which recognizes HLA-DR epitopes associated 
with the specificities DRw53 and DRw10 [14], a gift of Robert 
Winchester, Hospital for Joint Diseases, N ew York; TU-22, which 
recognizes a determinant of HLA-DQ molecules expressed in 
most individuals [15,1 6], a gift of Andreas Ziegler, University of 
Tubingen; Genox 3. 53, which recognizes HLA-DQ molecules 
associated with the specifi city DQw1 [17], a gift of Walter Bod-
mer, Imperial Cancer Research Fund Laboratories, London; IVD12, 
whi ch recognizes HLA-DQ molecules associated with the spec-
ifi city DQw3, produced loca lly [18] ; SDR 1.2, wh ich recognizes 
HLA-DQ molecules associated with the specificity DQw1 [1 9]; 
FA, which recognizes a monomorphic determinant of HLA-DP 
molecules [20] , a gift of Fritz Bach , University o f Minnesota; 
I-LR1, w hich recognizes HLA-DP molecules associated with the 
specifi cities DPw2 and DPw3 and DR molecules associated with 
the specifi city DRS [21] . 
Indirect Immunofluorescence Staining of Epidermal Whole 
Mounts for HLA-D Region Antigens Blister tops were washed 
in H anks' balanced salt solution for 5 min . They were then fi xed 
in acetone at room temperature for 5 min , followed by further 
washing in phosphate-buffered salin e (PBS) for 5-10 min . They 
were then incubated with undiluted primary antibody (i. e. , anti-
HLA-D R, anti-HLA-DP, o r anti-HLA-DQ antibody) 18 h over-
night at 4°C, followed by another was hing in PBS for 10 min . 
They were then stained with fluorescein isothiocyanate (F1TC)-
conju ga ted goat antimouse IgG (1: 10) for 30 min at 4°C , washed 
in PBS for 10 min , coverslipped with low quenching para-phen-
ylene-diamine mounting medium, and viewed and pho tographed 
w ith a Leitz Orthoplan fluo rescence microscope under epi-illu-
mination. 
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Indirect Immunofluorescence Staining of Epidermal Whole 
Mounts for Simultaneous Demonstration of OKT -6 and 
HLA-D Region Antigens Blister tops were washed and fi xed 
in acetone as above. They were then stained with unl abeled pri-
mary antibody (undiluted) for 1 h at 4°C foll ow ed by 3 separate 
5-min washes. They were next stained w ith tetra methyl rhoda-
nl.ine isothiocyanate (TRITC)-conju gated goat antimouse 19 at 
1 :10 for 1 h at 4°C and w ashed in PBS for 15 min. They w ere 
then incubated with an irrelevant, unl abeled mouse monoclonal 
antibody of the sa me isotype (91 A3 at 1 : 10) fo r 1 h at 4°C fol-
lowed by a wash in PBS for 15 min to block any residual unbound 
binding sites on the TRITC-goat anti mouse immunoglobulin (the 
effectiveness o f this blockin g procedure was confirmed in a sep-
arate experim ent in which a FITC-conju gated mouse monoclonal 
antibod y [63D3] having a specifi city not expected to react with 
ELC was shown not to bind to an epiderm al whole mount fol-
lowing this blocking procedure [data not shown]). T he blister 
tops were next stained with a F1TC-conjuga ted OKT -6 murine 
monoclonal antibody (1: 10) fo r 1 h at 4°C, washed in PBS fo r 
15 min , and coverslipped with a low quenching para-phenylene-
diamine mounting medium. The slides were viewed and pho-
tographed with a flu o rescence microscope under both F1TC and 
TRITC excitation filter cubes separately . 
Quantitation of Surface Density of Langer hans Cells in Epi-
dermal Whole Mounts The sur face density of fluorescent ELC 
was determined by the use of a rectan gular photographic g rid 
that had been calibrated with a micrometer. This technique has 
been described in detail [22]. D ata are ex pressed as mean ± 1 SD 
of 10 randomly chosen microscopic fields . 
RESULTS 
The data in Ta ble I clea rly demonstrate that normal resting human 
epidermal dendritic cells are capable of expressing the gene prod-
ucts of all 3 HLA-D subregions (DP, DR, DQ) . Several of the 
po lymorphic determin ant reactive antibodies did not bind in sit-
uations where they would have been expected to do so based 
upon the knowled ge of their specificities and the individuals' HLA 
phenotypes . For example 109d6 did not bind with the epidermal 
dendritic cells of volunteers K.R. and B .M . Likewise, Genox 3.53 
did not bind to K.R.'s epiderm al dendritic cells. However, L243, 
which is reactive to a monomorphic DR determinant, bound 
strongly to the epidermal dendritic cells ofR.S., K .R., and B.M. 
We therefore feel that this discrepancy most likely resulted from 
a techni cal variation due to the relatively w ea k binding observed 
Table I. HLA-D Region Antigen Expression by Epidermal Dendriti c Cells 
Anti-HLA-DR 
L243 
ILR-2 
109d6 
Anti- HLA-DQ 
TU-22 
IV D12 
Gcnox 3.53 
SD R 1.2 
Anti-HLA-DP 
FA 
ILR- l 
Monoclonal 
Antibody 
Specificity 
Monomorphic 
DRwS2 
DHwS3 
DQwl, DQw3 
DQw3 
DQwl 
DQw l 
monomorphic 
DPw2, DPw3, DRS 
R. S. (DR4, 
DRw6, DRwS3, 
DQ w l, 
DQ w3)" 
+ + +/, 
+ + ' 
+ + 
+ 
++ 
ND 
+ + 
++ 
' Volunteer's initials (HLA-DR and - DQ ty pes). 
b + + + ::; stro ng ly Auo rcscing epidermal dend ritic cells. 
e - = negative. 
d + = weakl y flu orescing epiderm al dendritic cells. 
, + + = moderately Allo rescing epiderm al dendritic cells. 
fNot done. 
G.L. (DR4, DRS, 
DRwS2, DRwS3, K .R. (DIU , DR4, n.M. (D Rw6, DR7, 
DQw3,---) DRwS3, DQw l , D Qw3) DRwS3, DQwl, DQw2) 
+ ++ +++ + ++ 
+" ++ 
+ 
ND! ++ ++ 
++ + + 
+ + 
ND N D + 
ND ND ND 
ND + 
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Figure 1. Simultaneous demonstration in an epiderma l whole mount of O KT-6 and HLA-D R antigens using a double fluorochromc indirect im-
munoflu o rescence technique (sec " Materials and Methods"). A, The appca rance of the whole mount viewed en face with the fluorescein excitation 
fil te r c ube in place (OKT-6). 13, The same microscopic field viewed with the rhodamine fi ltcr cube in pbcc (HLA-DR; L243). Note that the entirc 
popula tio n of OKT-6-bearing dendritic Langerhans cells in (A) is also express ing the HLA-DR L243 dcte rminant in (B). X 8UO. 
with all of the polymorphic determinant reacti ve antibodies in 
this indirect immunofluorescence (IIF) technique. Unexpected an-
tibody binding was detected in on ly one instance (1 VD1 2 binding 
weakly with B.M.'s epidermal dend ritic cells). B.M. was not 
available for repea t study to confirm this observation. 
HO'Never, this type of analysis could not determine whether 
all or only a subpopulation of epidermal dendritic cells were ex-
pressing each of the HLA-D subregion gene products. We there-
fore use d a double label IIF technique to demonstrate the si mul-
tan eous expression of a known human ELC marker, OKT -6 [23], 
an d HLA-D region gene products. Figure 1 shows the same mi-
croscopic field of a do ubly labeled epidermal w hole mount from 
volunteer R. S. photographed under: (A) the FITC excitation filter 
cube (OKT-6); and (B) the TRITC excitation filter cube (HLA-
DR; L-243) . As ca n be seen all of the OKT-6-positive ELC are 
exp ressing the HLA-DR L243 determinant. The exact same re-
sults 'Ne re seen with similar preparations do ubl y labeled for OKT-
6 and HLA-DP (FA) and HLA-DQ (TU-22). N o green fluores-
cing cells (OKT-6 positi ve) were ever seen that were not also red 
flu o r escing (HLA-DR, -DP, or -DQ positive). Table II shows 
the r esults of a determination of the surface densities of OKT-6-
positive (green fluorescing) and HLA-DR, -DP, and - DQ positive 
(red) ft uorescing cells in doubly labeled epidermal whole mounts 
from 3 separate volunteers. As can be seen there were identical 
Table II. Surf.lce Density of HLA-D Region Antigen 
Bearing OKT -6-Positive Epidermal Langerhans Cells in Flexo r 
Forearm Skin 
Epidermal Langerhans Cells 
(cells/ mm2) 
Expt. 1" Expt. 2 
Anti-HLA-OR 
L243 689 ± 164.9" 887 ± 80.6 
OKT-6 689 ± 164.9 887 ± 80.6 
Anti-HLA-OP 
FA 706 ± 70.8 893 ± 127.2 
OKT-6 706 ± 70.8 893 ± 127.2 
Anti-HLA-OQ 
T U-22 640 ± 63.3 N D' 
Leu-l0 NO 781 ± 149.7 
OKT-6 640 ± 63.3 781 ± 149.7 
' Volunteer R.S. 
' Mean :!: I SO of 10 randoml y chosen microscopic fields . 
'Not d o ne. 
Expt. 3 
681 ± 102.2 
68 1 ± 102.2 
736 ± 108.2 
736 ± 108.2 
NO 
731 ± 115. 5 
73 1 ± 11 5.5 
numbers of O KT -6-positi ve and HLA-D R, -DP, and - DQ pos-
itive cell s in each of the 3 experiments. These resul ts clearly doc-
um ent that th e epiderm al dendritic cells th at were reactin g w ith 
the HLA-D region antibodies in our ll F technique were in fac t 
La ngerh ans cells and strongly sugges t that all O KT -6-positive 
ELC constitutively express HLA-DR, - DP, and -DQ gene prod-
ucts. 
DISC USSIO N 
This study has clearly show n th at normal human E LC consti-
tuti vel y express HLA-DR, -DQ, and -DP gene prod ucts . In ad-
dition it strongly suggests that 100% of O KT-6-positi ve E LC 
express HLA-DR, HLA-DP, and HLA-DQ antigens, a find ing 
which is in contras t to several earlier studies. Whereas severa l 
in ves tigators have previously suggested that all OKT -6-positive 
ELC express HLA-DR [24,25], Berman et al [2,51 have presented 
data which suggest that only about 50% ofOKT-6-positi ve ELC 
express detectable levels of DR antigen by immunoAuorescence 
microscopic techniques . Similar results have been obtained by 
others as well [3,4]. There are at least 2 possibl e explanations for 
the disparity between our findings and th ose of the previous 
studies. O ne possibility would relate to an apparent difference in 
the cell surface distribution ofOKT-6 and HLA-DR antigens on 
E LC in situ . We have noted that the OKT-6 antigen is relatively 
evenly distributed over the cell body and dendritic surfaces whereas 
HLA-DR is often concentrated on the cel l body, sometimes even 
giving the appea rance of localizing asy mmetri ca ll y to one side of 
the cell bod y plasma membrane. A simil ar distribution of la an-
tigens can be seen on mouse ELC (personal communication , Pau l 
R. Bergstresser). This difference in surface distribution ofOKT-
6 and HLA-DR can be seen to some degree in Fig 1. Several of 
the earlier studies w hich suggested that on ly a subpopulation of 
O KT-6-positive ELC expressed HLA-DR relied exclusively on 
immunoflu orescence o r immunoperoxidase detection of antibody 
binding in frozen o r fix ed sections of intac t skin 13,4]. Because 
of the mo re even distribution of the O KT -6 antigen over the cell 
body and dendrites of ELC, one might gain the impression that 
there are a grea ter number of OKT-6-positi ve than HLA-DR-
positive dendritic cells in any given frozen section. O ur technique 
of double labeling epidermal w hole mounts effectively obv iates 
this problem . Berman et ail S] also used an epiderm al w hole 
mount technique; however they employed onl y a sing le label 
system .. Another possible explana tion fo r the disparity between 
our findin gs and those of others could relate to the fact that not 
all monoclonal anti-DR antibodies are likely to be eq uall y sen-
sitive in detecting these cell surface antigens . If so me ELC express 
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greater su rface densities of HLA-DR antigen than do others as 
has been suggested by some workers [24], it is possible that certain 
less sensitive HLA-DR antibodies might not identify a subpop-
ulation of ELC which expressed lower HLA-DR surface antigen 
densities. In support of this possibility is the fact that different 
monoclonal anti-HLA-DR antibodies were used in each of the 
previously ci ted studies [2-5,24,25]. The data in Table I also 
support this possibility. L243 produced a much stronger fluores-
cence end point than did similar concentrations of either of the 
other 2 anti-DR antibodies used in this study , ILR-2 and 109D6. 
O ur study strongly suggests that ELC, like other members of 
the human dendritic, antigen-presenting cell series [26,27] un i-
form ly express HLA-DQ gene products constitutively. T his fact 
would distinguish ELC from peripheral blood monocytes since 
only about 50% of these cells in a resting state have detectable 
HLA-DQ antigens [7,8J. Since the expression of HLA-DQ de-
terminants by a cell has been suggested to correlate positively 
with its nominal antigen- as we/J as alloantigen-presenting effi-
ciency [7,28], our findings would also support the idea that the 
ELC might be one of the most efficient nominal antigen- as well 
as alloan tigen antigen-presenting cell types [29] present in the 
human body, as has been suggested to be the case fo r extracu-
taneous human dendritic cells [26,30]. 
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